REGENXBIO Inc. (RGNX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

REGENXBIO Inc.

NASDAQ: RGNX · Real-Time Price · USD
10.43
-0.15 (-1.42%)
At close: Oct 03, 2025, 3:59 PM
10.57
1.34%
After-hours: Oct 03, 2025, 05:46 PM EDT

REGENXBIO Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
57.53M 34.52M 96.95M 345.21M
Short-Term Investments
177.16M 240.74M 267.69M 112.23M
Long-Term Investments
10.18M 38.87M 200.56M 391.91M
Other Long-Term Assets
6.5M 7.54M 9.93M 10.72M
Receivables
20.47M 26.34M 28.08M 32.44M
Inventory
n/a n/a 13.9M 18.75M
Other Current Assets
12.68M 18.85M 9.35M 10.2M
Total Current Assets
278M 334.97M 415.98M 518.83M
Property-Plant & Equipment
171.31M 192.59M 206.8M 192.45M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
187.99M 239M 417.29M 595.08M
Total Assets
465.99M 573.97M 833.27M 1.11B
Account Payables
22.8M 22.79M 27.21M 11.39M
Deferred Revenue
115K 148K 1.83M 3.33M
Short-Term Debt
7.9M n/a 6M 1.75M
Other Current Liabilities
20.46M 86.04M 71.33M 92.4M
Total Current Liabilities
103.19M 130.27M 130.43M 130.47M
Long-Term Debt
25.38M n/a n/a n/a
Other Long-Term Liabilities
29.01M 49.73M 97.84M 134.21M
Total Long-Term Liabilities
103.14M 131.96M 186.64M 219.13M
Total Liabilities
206.34M 262.23M 317.07M 349.61M
Total Debt
82.03M 89.29M 94.8M 86.68M
Book Value
259.65M 311.74M 516.2M 764.3M
Book Value Per Share
5.24 7.13 11.96 18.01
Common Stock
5K 4K 4K 4K
Retained Earnings
-932.15M -705.05M -441.55M -161.23M
Comprehensive Income
-741K -4.43M -15.4M -2.57M
Shareholders Equity
259.65M 311.74M 516.2M 764.3M
Total Investments
187.34M 279.61M 468.25M 504.14M